Showing results (1-10 of 487) with videos related to
Sort By:
Pageof 49
The Australasian Journal of Dermatology|May 25, 2011
Predicting melanoma risk for the Australian populationVictoria Mar, Rory Wolfe, John W KellyThe Australasian Journal of Dermatology|November 29, 2013
Diagnostic accuracy of malignant melanoma according to subtypeMatthew J Lin, Victoria Mar, Catriona McLean, et al.Journal of the American Academy of Dermatology|November 28, 2012
Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, AustraliaVictoria Mar, Hugh Roberts, Rory Wolfe, et al.The Australasian Journal of Dermatology|January 16, 2016
Scalp melanoma: Distinctive high risk clinical and histological featuresCharles Xie, Yan Pan, Catriona McLean, et al.Journal of Cancer Prevention|July 7, 2025
Chemoprevention of Keratinocyte Cancers: Could Aspirin Be the Solution?Emma Hiscutt, Suzanne Orchard, Rory Wolfe, et al.The Australasian Journal of Dermatology|May 6, 2022
Sensitivity of two Australian melanoma risk tools to identify high-risk individuals among people presenting with their first primary melanomaKatrina Tan, Serigne N Lo, Anne E Cust, et al.Journal of the American Academy of Dermatology|April 18, 2017
Impact of scalp location on survival in head and neck melanoma: A retrospective cohort studyCharles Xie, Yan Pan, Catriona McLean, et al.The British Journal of Dermatology|May 4, 2026
Evaluating COVID-19 Pandemic Impact on Melanoma Incidence and factors in Regions with Different Infection Control StrategiesCecilia Sand, Dilki Jayasinghe, Rory Wolfe, et al.The Australasian Journal of Dermatology|December 28, 2019
The anatomic distribution of cutaneous melanoma: A detailed study of 5141 lesionsEdmund Wee, Rory Wolfe, Catriona Mclean, et al.Journal of the American Academy of Dermatology|September 23, 2018
Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survivalEdmund Wee, Rory Wolfe, Catriona Mclean, et al.Pageof 49